Table 2.
Echocardiographic data.
Total | Amyloidosis | Other heart failure (wall > 12 mm) | P | |
---|---|---|---|---|
Interventricular septum [mm] | 15 ± 3 | 16 ± 3 | 14 ± 3 | 0.002* |
LV posterior wall [mm] | 13 ± 3 | 14 ± 3 | 11 ± 2 | < 0.001* |
LVEDD [mm] | 50 ± 7 | 48 ± 7 | 53 ± 6 | 0.004* |
LVESD [mm] | 35 ± 7 | 35 ± 7 | 35 ± 6 | 0.086 |
LVEDVI [cm3/m2] | 55 ± 17 | 51 ± 18 | 59 ± 16 | 0.004* |
LVESVI [cm3/m2] | 26 ± 11 | 25 ± 11 | 27 ± 12 | 0.49 |
LV mass [g] | 243 ± 68 | 259 ± 76 | 224 ± 53 | 0.026* |
Indexed mass [g/m2] | 138 ± 38 | 151 ± 43 | 123 ± 23 | 0.002* |
LA volume [cm3] | 53 ± 17 | 55 ± 17 | 51 ± 17 | 0.5 |
RA area [cm2] | 25 ± 8 | 27.4 ± 8.4 | 22.2 ± 5.7 | 0.04* |
RV basal diameter [mm] | 40 ± 7 | 40 ± 9 | 40 ± 5 | 0,87 |
E/A ratio | 1.4 ± 0.9 | 1.7 ± 1 | 1 ± 0.4 | 0.062 |
E/e′ ratio | 17.3 ± 7.1 | 18.1 ± 7.2 | 16.4 ± 7 | 0.36 |
Relative apical sparing | 1.7 ± 0.8 | 2.2 ± 0.9 | 1.03 ± 0.4 | 0.04 |
Global longitudinal strain [%] | −12 ± 5.5 | −19 ± 0.7 | 0.078 | |
TAPSE [mm] | 18 ± 5 | 16 ± 5 | 20 ± 4 | 0.004* |
S′ wave RV | 11.4 ± 4 | 11.2 ± 4.7 | 11.7 ± 2.1 | 0.7 |
PASP [mmHg] | 44 ± 15 | 44 ± 15 | 44 ± 14 | 0.96 |
LV ejection fraction [%] | 54 ± 10 | 52 ± 10 | 55 ± 12 | 0.18 |
Effusion presence | 14 (17%) | 9 (23.7%) | 5 (14.3%) | 0.56 |
Interventricular septum thickness, left ventricular posterior wall thickness, left ventricular mass, left ventricular end-diastolic diameter, left ventricular end-diastolic indexed volume, tricuspid annular plane systolic excursion, right atrial area and strain relative apical sparing were significantly associated with the diagnosis of cardiac amyloidosis.
LV — left ventricle; LA — left atrium; RV — right ventricle; RA — right atrium; LVEDD — left ventricular end-diastolic diameter; LVESD — left ventricular end-systolic diameter; LVEDVI — left ventricular end-diastolic volume index; LVESVI — left ventricular end-systolic volume index; TAPSE — tricuspid annular plane systolic excursion; PASP — pulmonary artery systolic pressure